Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345241 · ClinicalTrials.gov registry record · NA
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
A NA study of Keratoconjunctivitis Sicca, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00345241: Completed NA study of Keratoconjunctivitis Sicca, sponsored by University of Texas Southwestern Medical Center.
NCT00345241 is a NA study of Keratoconjunctivitis Sicca that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 12 participants, below the 176-participant average among 10 other Keratoconjunctivitis Sicca trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00345241, a NA study of Keratoconjunctivitis Sicca, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate tear film stability of a market lubricant therapeutic eye drop versus saline when using Evaporometry and Interferometry in patients with a diagnosis of Keratoconjunctivitis Sicca (KCS). The purpose of this research is to evaluate evaporative parameters and tear film quality when using Systane lubricating eye drops versus saline in the eyes of dry eye patients at pre-instillation and at 30 and 60 minutes post instillation of drop(s).
Conditions Studied
Interventions
- DRUG Systane Ocular Drops (OTC)
- DRUG Placebo - Saline Drops
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-12 |
| Phase | NA |
What the finished NCT00345241 record still lists
NCT00345241 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 176-participant average among 10 other Keratoconjunctivitis Sicca trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Keratoconjunctivitis Sicca appearing as the primary indexed condition, and to 2 interventions - of which Systane Ocular Drops (OTC) is the first listed.
NCT00345241 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00345241 about?
NCT00345241 is a clinical study titled "Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points". To evaluate tear film stability of a market lubricant therapeutic eye drop versus saline when using Evaporometry and Interferometry in patients with a diagnosis of Keratoconjunctivitis Sicca (KCS). The purpose of this research is to evaluate evaporative parameters and tear film quality when using Sy...
What is the current status of trial NCT00345241?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2006-01. Estimated completion is 2006-12.
What conditions does trial NCT00345241 study?
This clinical trial studies the following conditions: Keratoconjunctivitis Sicca.
What interventions are being tested in trial NCT00345241?
The interventions under investigation include: Systane Ocular Drops (OTC) (DRUG), Placebo - Saline Drops (DRUG).
Who is sponsoring clinical trial NCT00345241?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00345241 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconjunctivitis Sicca
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00345241's enrollment target sits among peer trials
12 11th of 10 the lowest of 10 other Keratoconjunctivitis Sicca trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keratoconjunctivitis Sicca trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
COMPLETED · NA
-
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
COMPLETED
-
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
COMPLETED · Phase 3
-
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
COMPLETED · Phase 2
-
Effects of Dry Eye Treatments on the Ocular Surface
COMPLETED · Phase 4
-
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia